CN111635752B - Gold nanorod/DNA/carbon dot nano hybrid material and preparation method and application thereof - Google Patents
Gold nanorod/DNA/carbon dot nano hybrid material and preparation method and application thereof Download PDFInfo
- Publication number
- CN111635752B CN111635752B CN202010296389.4A CN202010296389A CN111635752B CN 111635752 B CN111635752 B CN 111635752B CN 202010296389 A CN202010296389 A CN 202010296389A CN 111635752 B CN111635752 B CN 111635752B
- Authority
- CN
- China
- Prior art keywords
- dna
- carbon
- gold
- gold nanorod
- stranded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title claims abstract description 158
- 229910052799 carbon Inorganic materials 0.000 title claims abstract description 104
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 title claims abstract description 103
- 239000000463 material Substances 0.000 title claims abstract description 74
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 238000003384 imaging method Methods 0.000 claims abstract description 80
- 108020004414 DNA Proteins 0.000 claims description 127
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 45
- 102100033072 DNA replication ATP-dependent helicase DNA2 Human genes 0.000 claims description 22
- 101000927313 Homo sapiens DNA replication ATP-dependent helicase DNA2 Proteins 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 18
- 239000007822 coupling agent Substances 0.000 claims description 15
- 125000000524 functional group Chemical group 0.000 claims description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 10
- XEIPQVVAVOUIOP-UHFFFAOYSA-N [Au]=S Chemical compound [Au]=S XEIPQVVAVOUIOP-UHFFFAOYSA-N 0.000 claims description 9
- 239000007853 buffer solution Substances 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 230000035484 reaction time Effects 0.000 claims description 8
- 102000053602 DNA Human genes 0.000 claims description 7
- 125000003277 amino group Chemical group 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- 239000002086 nanomaterial Substances 0.000 claims description 7
- 239000000872 buffer Substances 0.000 claims description 6
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 5
- 230000004913 activation Effects 0.000 claims description 5
- 238000001027 hydrothermal synthesis Methods 0.000 claims description 5
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims description 4
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- 150000001735 carboxylic acids Chemical class 0.000 claims description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 239000002243 precursor Substances 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 2
- CCMKPCBRNXKTKV-UHFFFAOYSA-N 1-hydroxy-5-sulfanylidenepyrrolidin-2-one Chemical compound ON1C(=O)CCC1=S CCMKPCBRNXKTKV-UHFFFAOYSA-N 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 230000000295 complement effect Effects 0.000 claims description 2
- 239000012043 crude product Substances 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 238000003745 diagnosis Methods 0.000 abstract description 7
- 206010028980 Neoplasm Diseases 0.000 abstract description 6
- 201000011510 cancer Diseases 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 6
- 108091023037 Aptamer Proteins 0.000 abstract description 4
- 201000001320 Atherosclerosis Diseases 0.000 abstract description 4
- 208000003174 Brain Neoplasms Diseases 0.000 abstract description 4
- 206010006187 Breast cancer Diseases 0.000 abstract description 4
- 208000026310 Breast neoplasm Diseases 0.000 abstract description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract description 3
- 201000005202 lung cancer Diseases 0.000 abstract description 3
- 208000020816 lung neoplasm Diseases 0.000 abstract description 3
- 238000011895 specific detection Methods 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 description 14
- 238000010998 test method Methods 0.000 description 14
- 230000000694 effects Effects 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 238000000862 absorption spectrum Methods 0.000 description 10
- 239000006185 dispersion Substances 0.000 description 10
- 238000002189 fluorescence spectrum Methods 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 229910052737 gold Inorganic materials 0.000 description 5
- 239000010931 gold Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000012984 biological imaging Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000001338 self-assembly Methods 0.000 description 3
- SSOORFWOBGFTHL-OTEJMHTDSA-N (4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-5-carbamimidamido-1-[[(2S)-5-carbamimidamido-1-[[(1S)-4-carbamimidamido-1-carboxybutyl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-5-oxopentanoic acid Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SSOORFWOBGFTHL-OTEJMHTDSA-N 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108700011259 MicroRNAs Proteins 0.000 description 1
- VYLQGYLYRQKMFU-UHFFFAOYSA-N Ochratoxin A Natural products CC1Cc2c(Cl)cc(CNC(Cc3ccccc3)C(=O)O)cc2C(=O)O1 VYLQGYLYRQKMFU-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- RWQKHEORZBHNRI-BMIGLBTASA-N ochratoxin A Chemical compound C([C@H](NC(=O)C1=CC(Cl)=C2C[C@H](OC(=O)C2=C1O)C)C(O)=O)C1=CC=CC=C1 RWQKHEORZBHNRI-BMIGLBTASA-N 0.000 description 1
- DAEYIVCTQUFNTM-UHFFFAOYSA-N ochratoxin B Natural products OC1=C2C(=O)OC(C)CC2=CC=C1C(=O)NC(C(O)=O)CC1=CC=CC=C1 DAEYIVCTQUFNTM-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- RPENMORRBUTCPR-UHFFFAOYSA-M sodium;1-hydroxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].ON1C(=O)CC(S([O-])(=O)=O)C1=O RPENMORRBUTCPR-UHFFFAOYSA-M 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- JLEXUIVKURIPFI-UHFFFAOYSA-N tris phosphate Chemical compound OP(O)(O)=O.OCC(N)(CO)CO JLEXUIVKURIPFI-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/02—Use of particular materials as binders, particle coatings or suspension media therefor
- C09K11/025—Use of particular materials as binders, particle coatings or suspension media therefor non-luminescent particle coatings or suspension media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0052—Small organic molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
- A61K49/0067—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle quantum dots, fluorescent nanocrystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y20/00—Nanooptics, e.g. quantum optics or photonic crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/58—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing copper, silver or gold
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/65—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing carbon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4738—Diffuse reflection, e.g. also for testing fluids, fibrous materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
Abstract
The invention discloses a gold nanorod/DNA/carbon dot nano hybrid material and a preparation method and application thereof. The gold nanorod/DNA/carbon point nano hybrid material takes a gold nanorod as a core, takes DNA as a medium, and couples carbon points through covalent bonds, so that the carbon points are distributed around the gold nanorod in a satellite emission shape to form a 'core-satellite' structure. The preparation method of the gold nanorod/DNA/carbon dot nano hybrid material is mild and effective. The hybrid material simultaneously realizes the application of noninvasive diffuse reflection imaging and fluorescence lifetime imaging, thereby realizing multi-modal imaging and having good application prospect in the aspect of accurate diagnosis of diseases caused by atherosclerosis. When the DNA is the specific aptamer DNA, the material is expected to realize specific detection and targeted treatment on most cancer diseases such as breast cancer, lung cancer, brain tumor and the like.
Description
Technical Field
The invention relates to the technical field of biological imaging. More particularly, relates to a gold nanorod/DNA/carbon dot nano hybrid material, a preparation method and application thereof.
Background
Cancer is a worldwide recognized disease with a very high mortality rate, and early diagnosis helps to improve the survival rate of patients. A single imaging technology cannot meet the requirement of diagnosis, and multi-modal imaging is gradually becoming a research hotspot in the field of biological imaging. The nanometer hybrid material composed of multiple components breaks through the limitation of single component, can acquire multi-directional information through multi-mode imaging to realize more comprehensive diagnosis, and is even expected to realize diagnosis and treatment integration.
Diffuse reflectance imaging (DR) and Fluorescence Lifetime Imaging (FLIM) are two new, safe, easy-to-handle imaging techniques. Among other things, DR can provide important morphologies of biological tissue through processing of optical signals, and does not require high radiation intensity or high penetration depth. FLIM is being used more and more widely for quantitative studies of cellular microenvironments and biomedical applications, where high spatial resolution can provide temporal and spatial information of the fluorescence lifetime variation of fluorescently labeled components in images. The combination of DR and FLIM enables the exploration of optical properties and molecular imaging of biological tissues.
Due to the existence of plasmon, the gold nanorods show unique optical characteristics and are suitable DR imaging contrast agents. However, the gold nanorods are not low in fluorescence quantum efficiency enough to carry out FLIM imaging, and a material with high fluorescence quantum efficiency needs to be introduced. In recent years, carbon dots have been widely used in the field of bio-imaging due to advantages such as excellent fluorescence properties and excellent biocompatibility. The gold nanorods and the carbon dots are combined into the nano hybrid material, different optical properties and excellent biocompatibility of the gold nanorods and the carbon dots are integrated, and the nano hybrid material is a multifunctional imaging material suitable for DR and FLIM. However, the assembly of gold nanorods and carbon dots requires a medium as a bridge for connection. Gold nanorods/silica/carbon dots and gold nanorods/polyethylene glycol/carbon dots hybrid nanomaterial [ Multimodal biomorphic basal on gold nanoparticles and carbon dot nanohybrids as a novel tool for atherospermis detection, Nano Research, 2018, 11, 1262-; gold Rod-Polyethylene Glycol-Carbon Dot Nanohybrids as Phototheranostic Probes, Nanomaterials,2018,8,706 have been developed, but relatively, the thickness of silica is not easily controlled precisely, the rigidity of Polyethylene Glycol chains is insufficient, and the regulation of distance is not easily realized.
DNA has been used for nanoscale self-assembly [ DNA as a power tool for morphology control, spatial position, and dynamic assembly of nanoparticles, Acc. chem. Res.47(2014) 1881-1890 ], and double strands have certain rigidity and can be controlled at high degree of distance. The multifunctional nano hybrid material prepared by using DNA as a framework has important application in aspects of biological imaging, drug delivery, disease treatment, microorganism detection and the like. [ highly effective platinum Nanorods and Upconversion Core-saturated hybridization viruses, Adv. Mater.2016,28, 898-904 ] AS1411-conjugated gold nanospheres and the needle for sparse therapy, Oncotarget 6(2015) 22270-22281 [ fluorescent methods for quick detection of ochratoxin A in flowing and using nitro gene bonded carbon dots and silver nanoparticles, Takara 182 (363) 370 ] gold Nanorods/carbon Nanorods and hybrid materials proposed by the present invention have a promising prospect for achieving accurate diagnosis of atherosclerosis and DR-mediated disease. The detection of breast Cancer, [ Gold-Quantum Dot Core-Specific Assembly for Lighting Up MicroRNA In Vitro and In Vivo, [ New-Generation Cancer-Specific Hybrid materials ] MAGE-A3 Persistent Luminescence characterization for In Situ prediction and characterization, 10.1002/2013741 ] brain tumor, [ target for imaging target and therapeutic target of Cancer ] and the like can be achieved when the DNA is a Specific Aptamer DNA such AS AS1411, MAGE-A3 or GBI-10.
Disclosure of Invention
The first purpose of the invention is to provide a gold nanorod/DNA/carbon dot nano hybrid material.
The second purpose of the invention is to provide a preparation method of the gold nanorod/DNA/carbon dot nano hybrid material.
The third purpose of the invention is to provide the application of the gold nanorod/DNA/carbon dot nano hybrid material in diffuse reflection imaging and fluorescence lifetime imaging.
In order to achieve the purpose, the invention adopts the following technical scheme:
one aspect of the present invention provides a gold nanorod/DNA/carbon dot nanohybrid material, comprising: gold nano-rod,
A double-stranded DNA molecule and a carbon dot; the double-stranded DNA molecule comprises single-stranded DNA1 and complementary single-stranded DNA 2;
the 5 'end of the single-stranded DNA1 is combined with the gold nanorod through a gold-sulfur coordination bond, and the 5' end of the single-stranded DNA2 is combined with a carbon point through a covalent bond.
The gold nanorod/DNA/carbon point nano hybrid material takes the gold nanorod as a core, takes the DNA as a connecting medium (bridge) and leads carbon points to be closely distributed around the gold nanorod in a satellite emission shape to form a 'core-satellite' structure. The structure has high stability and good dispersibility; the gold nanorods are combined with the single-stranded DNA1 through a gold-sulfur coordination bond, and the carbon dots are connected with the single-stranded DNA2 through covalent interaction; the material is used for multi-modal imaging combining fluorescence lifetime imaging and diffuse reflection imaging, and has high sensitivity.
Further, the length-diameter ratio of the gold nanorod is 2-6, the diameter is 10-30nm, the length is 20-100nm, and the longitudinal SPR ultraviolet absorption peak is between 600 and 900 nm.
Furthermore, the 5' end of the single-stranded DNA1 is modified with sulfydryl and forms a gold-sulfur coordination bond with the gold nanorod; the 5' -end of the single-stranded DNA2 is modified with amino or carboxyl;
the particle size of the carbon dots is 1-10nm, and the fluorescence lifetime is 1.0-15.0 ns; the carbon point is modified with a functional group and reacts with an amino group or a carboxyl group at the 5' end of the single-stranded DNA2 to form a covalent bond.
In the gold nanorod/DNA/carbon dot nano hybrid material, the gold nanorod is combined with DNA through a gold-sulfur coordination bond, and the carbon dot is combined with the DNA through covalent action. Compared with physical adsorption, the material has better stability and is not easily decomposed in complex chemical environment in cells.
Further, the ultraviolet visible absorption spectrum of the gold nanorod/DNA/carbon dot nano hybrid material has an absorption peak at 500-540nm and a maximum absorption peak at 600-900 nm.
The invention also provides a preparation method of the gold nanorod/DNA/carbon dot nano hybrid material, which comprises the following steps:
1) preparing gold nanorods;
2) reacting the single-stranded DNA1 with the gold nanorods to form gold-sulfur coordination bonds, and preparing a gold nanorod/DNA 1 compound;
3) preparing a carbon dot containing a functional group;
4) reacting the carbon dot containing the functional group with the single-stranded DNA2 to form a covalent bond, and preparing a carbon dot/DNA 2 complex;
5) self-assembling the gold nanorod/DNA 1 compound obtained in the step 2) and the carbon dot/DNA 2 compound obtained in the step 4) in a PBS buffer solution to form the gold nanorod/DNA/carbon dot nano hybrid material.
Further, the 5 'end of the single-stranded DNA1 is modified with a thiol group, and the 5' end of the single-stranded DNA2 is modified with an amino group.
Further, the step 2) specifically comprises: single-stranded DNA1 and gold nanorods were added to the buffer in sequence, and the reaction was carried out at room temperature with shaking.
Preferably, the molar ratio of the single-stranded DNA1 to the gold nanorods is 250:1-1000:1, and the reaction time is 0.5-24 h.
Preferably, the buffer solution of step 2) is not particularly limited in the present invention, as long as it can provide a suitable reaction environment. For example, Tris borate buffer (TBE), Tris acetate buffer (TAE), Tris-EDTA buffer (TE), Tris phosphate buffer (TPE), Phosphate Buffer (PBS), etc. may be used. The above buffers are all buffers commonly used in the art and can be selected arbitrarily. TBE is preferred in the present invention, and more preferably, the buffer comprises 1 XTBE, 500mM sodium chloride (NaCl) and 0.02% Sodium Dodecyl Sulfate (SDS) solution, the pH thereof can be adjusted to 3.0-6.0, and it can be prepared by dissolving 2.16g Tris base, 1.1g boric acid, 0.8mL of 0.5M EDTA (pH 8.0) in 200mL ultrapure water.
In a preferred embodiment, step 2) comprises:
washing CTAB on the surface of the gold nanorod obtained in the step 1) with water, and dispersing the gold nanorod in water to obtain a gold nanorod dispersion liquid; adding DNA1 with one end being modified by sulfydryl into a buffer solution containing TBE, NaCl, HCl and SDS solution, mixing uniformly, then adding gold nanorod dispersion liquid, and fully oscillating at room temperature to obtain the gold nanorod dispersion liquid grafted with DNA 1; then centrifuging and washing to obtain a gold nanorod/DNA 1 compound; wherein the molar ratio of the DNA1 to the gold nanorods is 250:1-1000:1, and the reaction time is 0.5-24 h.
Further, the step 3) specifically comprises: taking organic carboxylic acid or organic amine as a precursor and deionized water as a solvent, preparing a carbon dot crude product by a hydrothermal method, and dialyzing and purifying to obtain the carbon dot.
Preferably, the reaction temperature of the hydrothermal method is 120-200 ℃, and the reaction time is 4-12 h;
preferably, the organic carboxylic acid is one or a combination of more than two of citric acid, lower fatty acid and amino acid; the organic amine is one or the combination of more than two of ethylenediamine, aniline, phenylenediamine, diethanolamine and hydrazine hydrate.
Further, the step 4) specifically includes: adding a coupling agent into the aqueous solution of the carbon dots containing the functional groups for activation, then adding the single-stranded DNA2, and carrying out the reaction by shaking in the dark.
Preferably, the coupling agent is one or a combination of more than two of 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride (EDC), Dicyclohexylcarbodiimide (DCC), N-hydroxythiosuccinimide (sulfo-NHS) and N-hydroxysuccinimide (NHS); when the number of the coupling agents is two, the proportion of the two coupling agents is adjusted according to actual needs; still further, the coupling agent is selected from the group consisting of 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS).
The coupling agent adopted by the invention has good catalytic activity in a water system, the reaction condition is mild and controllable, and no pollutant is generated.
Preferably, the activation time is 15-30 min.
Preferably, the molar ratio of the carbon dots containing functional groups to the single-stranded DNA2 is 50:1 to 500:1, and the molar ratio of the coupling agent to the carbon dots containing functional groups is 100:1 to 1000: 1.
In a preferred embodiment, step 4) specifically comprises: dispersing the carbon dots obtained in the step 3) in water, sequentially adding a coupling agent, activating for 15-30min in a dark environment, quickly adding the single-stranded DNA2 modified with carboxyl or amino at the 5' end, and oscillating for 12-24h in a dark place; then centrifugating and washing by an ultrafiltration tube to obtain the carbon dot/DNA 2 complex.
In a preferred embodiment, step 5) comprises in particular: adding the gold nanorod/DNA 1 complex obtained in the step 2) into PBS buffer solution containing the carbon dot/DNA 2 complex obtained in the step 4) for self-assembly; then centrifuging and washing to obtain the gold nanorod/DNA/carbon dot nano hybrid material aqueous solution.
Further, the molar ratio of the carbon dots to the gold nanorods in the step 5) is 10:1-50: 1.
The gold nanorod/DNA/carbon dot nano hybrid material prepared by the invention has good water solubility, wherein the gold nanorod is connected with DNA through a gold-sulfur coordination bond, the carbon dot is connected with the DNA through an amide bond, and the two single-stranded DNAs 1 and 2 are complementarily paired through hydrogen bonds between bases, so that the gold nanorod/DNA/carbon dot nano hybrid material has good stability.
The invention further provides application of the gold nanorod/DNA/carbon dot nano hybrid material in diffuse reflection imaging and fluorescence lifetime imaging. Therefore, multi-mode imaging is realized, and the method has good application prospect in the aspect of accurate diagnosis of diseases caused by atherosclerosis. When the DNA is the specific aptamer DNA, the material is expected to realize specific detection and targeted treatment on most cancer diseases such as breast cancer, lung cancer, brain tumor and the like.
The invention has the following beneficial effects:
(1) the preparation method of the gold nanorod/DNA/carbon dot nano hybrid material provided by the invention is mild and effective, not only ensures the close attachment of carbon dots, but also maintains the surface plasmon resonance effect of the gold nanorod.
(2) The gold nanorod/DNA/carbon dot nano hybrid material provided by the invention has excellent optical properties of the gold nanorod and remarkable fluorescence property of the carbon dot.
(3) The gold nanorod/DNA/carbon dot nano hybrid material skillfully utilizes different optical properties of the gold nanorod and the Carbon Dots (CDs), and effectively proves good response effect of the gold nanorod/DNA/carbon dots in noninvasive multi-modal imaging.
(4) According to the gold nanorod/DNA/carbon dot nano hybrid material provided by the invention, the connection of CDs not only endows the gold nanorods with better fluorescence response in FLIM imaging, but also obtains better diffuse reflection effect than the gold nanorods.
(5) The gold nanorod/DNA/carbon dot nano hybrid material provided by the invention realizes DR and FLIM multi-modal imaging, and has a good application prospect in the aspect of accurate diagnosis of diseases caused by atherosclerosis. When the DNA is the specific aptamer DNA, the material is expected to realize specific detection and targeted treatment on most cancer diseases such as breast cancer, lung cancer, brain tumor and the like.
Drawings
The following describes embodiments of the present invention in further detail with reference to the accompanying drawings.
FIG. 1 shows the TEM image of the gold nanorod/DNA/carbon dot hybrid material in example 1.
FIG. 2 shows UV-visible absorption spectra of Gold Nanorods (GNRs), gold nanorod/DNA complexes (GNR-DNA), and gold nanorods/DNA/carbon dots (GNR-DNA-CDs) in example 1.
FIG. 3 shows fluorescence emission spectra of gold nanorods/DNA/carbon dots in example 1.
FIG. 4 shows the results of diffuse reflectance imaging of blanks (controls), gold nanorods/DNA complexes (GNR-DNA) in comparative example 1, and gold nanorods/DNA/carbon dots (GNR-DNA-CDs) in a phantom like tissue of example 1.
FIG. 5 shows a histogram of the mean slopes of diffuse reflectance imaging of blanks (Control) and gold nanorods/DNA/carbon dots (GNR-DNA-CDs) in the phantom of tissue-like material in example 1.
FIGS. 6a, 6b, and 6c show the fluorescence lifetime imaging graphs and lifetime value fitting results of the blank (Control), the gold nanorod/DNA complex (GNR-DNA) in comparative example 1, and the gold nanorod/DNA/carbon dots (GNR-DNA-CDs) in the phantom of the tissue-like structure in example 1, respectively.
FIG. 6d, FIG. 6e, and FIG. 6f show the fluorescence lifetime value fitting results of blank (Control), gold nanorod/DNA complex (GNR-DNA) in comparative example 1, and gold nanorod/DNA/carbon dots (GNR-DNA-CDs) in the phantom of tissue-like body in example 1, respectively.
Detailed Description
In order to more clearly illustrate the invention, the invention is further described below with reference to preferred embodiments and the accompanying drawings. Similar parts in the figures are denoted by the same reference numerals. It is to be understood by persons skilled in the art that the following detailed description is illustrative and not restrictive, and is not to be taken as limiting the scope of the invention.
DNA1, DNA2, DNA1 'and DNA2' were all from Biotechnology engineering (Shanghai) Ltd.
Example 1
The preparation method of the gold nanorod/DNA/carbon dot nano hybrid material comprises the following steps:
1) gold nano-rod
Gold Nanorods [ Babak Nikoobacht, Mostafa A El-Sayed. preparation and Growth Mechanism of Gold Nanoros (NRs) Using Seed-media Growth method. chem. mater.2003,15, 1957-. The diameter of the prepared gold nanorod is about 17nm, the length of the prepared gold nanorod is about 58nm, the length-diameter ratio of the prepared gold nanorod is 3.4, the ultraviolet visible absorption peaks are 510 nm and 735nm, and a transmission electron microscope image of the gold nanorod can be seen in figure 1.
2) Gold nanorod/DNA 1 complex
The DNA1 has a sequence of 5'-SH-AGT CAG TAC AGT CAT TGC GT-3' (shown as a sequence table SEQ ID No. 1), 20 basic groups and SH represents a sulfydryl group.
And (3) centrifuging and washing the gold nanorod dispersion liquid by using deionized water, removing the coated CTAB, and dispersing the precipitate in water again. A buffer solution containing 1 XTBE, 500mM NaCl and 0.02% SDS solution by mass concentration was prepared, the pH of the solution was adjusted to 3.0 with HCl, and the mixture was thoroughly shaken and mixed. Then adding sulfhydryl DNA1 and a gold nanorod solution into the buffer solution in sequence, wherein the molar ratio of the DNA1 to the gold nanorods is 500:1, and continuously oscillating for 12 h. Then, the mixed solution is centrifugally washed for 3 times, and the precipitate is dispersed again to obtain a gold nanorod/DNA 1 complex solution.
3) Carboxyl functional carbon dots
1g of citric acid and 1mL of ethylenediamine were dissolved in 10mL of water, and then transferred to a hydrothermal reactor to carry out hydrothermal reaction at 200 ℃ for 5 hours, thereby obtaining a brownish red mixture containing carboxyl-functionalized carbon dots. And dialyzing the mixed solution of the carboxyl functionalized carbon dots to obtain the carboxyl functionalized carbon dots. The particle size of the obtained carbon dot is 2nm, and the fluorescence emission peak is 400-500 nm.
4) Carbon dot/DNA 2 complex
DNA2 sequence 5' -NH 2 -ACG CAA TGA CTG TAC TGA CT-3' (shown in SEQ ID No.2 of the sequence Listing), 20 basic groups, NH 2 Represents an amine group.
150 μ L of carbon dot dispersion (20mg/mL) was added sequentially with coupling agent EDC (100 μ L, 0.4M) and NHS (100 μ L, 0.4M) at a molar ratio of coupling agent to carbon dots of 100:1, and after 30min of activation, 10 μ L of DNA2(150 μ M) was added rapidly and shaken in the dark for 24 h. In order to remove the excess carbon dots and the coupling agent, the resulting mixture was centrifuged and washed by an ultrafiltration tube to obtain a carbon dot/DNA 2 complex.
5) Gold nanorod/DNA/carbon dot nano hybrid material
Adding the gold nanorod-DNA 1 into PBS buffer solution containing carbon dot-DNA 2 for self-assembly, wherein the molar ratio of the carbon dot to the gold nanorod is 20: 1. Shaking, mixing, placing in 60 deg.C water bath for 10min, taking out, placing in 37 deg.C water bath for 2h, taking out, and slowly cooling to room temperature. Then, excess carbon dot-DNA 2 was removed by centrifugation and washing. And dispersing the precipitate in PBS to obtain gold nanorod/DNA/carbon dot dispersion liquid. As shown in FIG. 2, the prepared gold nanorod/DNA/carbon dot has two characteristic absorption peaks of 520 nm and 765nm in an ultraviolet visible spectrum, and as shown in FIG. 3, the fluorescence emission spectrum has an emission peak of 400-500 nm.
And (3) diffuse reflection imaging test: the test was performed using an optical device (NEGOH-OP Technologies, Israel) for measuring the intensity of the reflected light, using the method described in [ Journal of biophotonics,2012,263 and 273 ], when the distance between the light source and the detector was changed from 1mm to 6mm, the intensity of the reflected light was collected and the data was processed using an oscilloscope. The test result is shown in fig. 4, the slope of the diffuse reflection light intensity-distance curve represents the effect of diffuse reflection imaging, and the greater the slope, the more sensitive the imaging and the better the effect. As can be seen from the combination of FIG. 5, the gold nanorod/DNA/carbon dot hybrid material has a larger slope and has better imaging effect and sensitivity.
Fluorescence lifetime imaging test: the scanning confocal microscope used was a PicoQuant MicroTime200, and the light source used was a 406nm picosecond pulsed laser. The test results are shown in fig. 6 a-6 f, and from FLIM imaging graphs, the gold nanorod/DNA/carbon dot hybrid nanomaterial prepared by the invention has a stronger fluorescence response signal, and the corresponding fluorescence lifetime is 6.4 ns.
Example 2
The material preparation method is the same as that of example 1, and only differs from the following method: the diameter of the gold nanorod prepared in the step 1) is about 20nm, the length is about 60nm, the length-diameter ratio is about 3.0, and the ultraviolet visible absorption peaks are 510 nm and 710 nm. The absorption peaks of the gold nanorod/DNA/carbon dot in an ultraviolet visible absorption spectrum are 510 nm and 720nm, and the emission peak of a fluorescence emission spectrum is 400-500 nm.
The diffuse reflection imaging test method is the same as that of the embodiment 1, and the performance of the gold nanorod/DNA/carbon dot nano hybrid material in diffuse reflection imaging is similar to that of the embodiment 1.
The fluorescence lifetime imaging test method is the same as that in the example 1, and the result of the gold nanorod/DNA/carbon dot nano hybrid material in the fluorescence lifetime imaging is similar to that in the example 1.
Example 3
The material preparation method is the same as that of example 1, and only differs from the following method: in steps 2) and 4), "the number of bases of DNA is 20" is replaced with "40".
The sequence of the DNA1 is changed into that of DNA 1': 5'-SH-GTC GCC TGC ATG AGC TGA GAA GTC AGT ACA GTC ATT GCG T-3' (shown in a sequence table SEQ ID No. 3).
The sequence of the DNA2 is changed into that of DNA 2': 5'-NH2-ACG CAA TGA CTG TAC TGA CTT CTC AGC TCA TGC AGG CGA C-3' (shown as sequence table SEQ ID No. 4). .
The absorption peaks of the gold nanorods/DNA/carbon dots in the ultraviolet visible absorption spectrum are 522 nm and 775nm, and the emission peak of the fluorescence emission spectrum is 400-500 nm.
The testing method of diffuse reflection imaging is the same as that of the embodiment 1, and the performance of the gold nanorod/DNA/carbon dot nano hybrid material in diffuse reflection imaging is similar to that of the embodiment 1.
The fluorescence lifetime imaging test method is the same as that in the example 1, and the result of the gold nanorod/DNA/carbon dot nano hybrid material in the fluorescence lifetime imaging is similar to that in the example 1.
Example 4
The material preparation method is the same as that of example 1, and only differs from the following method: in the step 2), "the molar ratio of the DNA to the gold nanorods is 500: 1" is replaced by "1000: 1". The absorption peaks of the gold nanorod/DNA/carbon dot in the ultraviolet visible absorption spectrum are 522 nm and 768nm, and the emission peak of the fluorescence emission spectrum is 400-500 nm.
The diffuse reflection imaging test method is the same as that of the embodiment 1, and the performance of the gold nanorod/DNA/carbon dot nano hybrid material in diffuse reflection imaging is similar to that of the embodiment 1.
The fluorescence lifetime imaging test method is the same as that in example 1, and the result of the gold nanorod/DNA/carbon dot nano hybrid material in fluorescence lifetime imaging is similar to that in example 1.
Example 5
The material preparation method is the same as that of example 1, and only differs from the following method: in the step 2), "the reaction time of DNA and gold nanorods is 12 h" is changed to "5 h". The absorption peaks of the gold nanorod/DNA/carbon dot in an ultraviolet visible absorption spectrum are 515 nm and 760nm, and the emission peak of a fluorescence emission spectrum is 400-500 nm.
The testing method of diffuse reflection imaging is the same as that of the embodiment 1, and the performance of the gold nanorod/DNA/carbon dot nano hybrid material in diffuse reflection imaging is similar to that of the embodiment 1.
The fluorescence lifetime imaging test method is the same as that in example 1, and the result of the gold nanorod/DNA/carbon dot nano hybrid material in fluorescence lifetime imaging is similar to that in example 1.
Example 6
The material preparation method is the same as that of example 1, and only differs from the following method: in the step 3), "the reaction time for preparing the carbon dots is 5 h" is changed to "12 h". The size of the carbon dots is 2-5nm, and the fluorescence emission peak is 400-500 nm. The absorption peaks of the gold nanorod/DNA/carbon dot in the ultraviolet visible absorption spectrum are 520 nm and 767nm, and the emission peak of the fluorescence emission spectrum is 400-500 nm.
The diffuse reflection imaging test method is the same as that of the embodiment 1, and the performance of the gold nanorod/DNA/carbon dot nano hybrid material in diffuse reflection imaging is similar to that of the embodiment 1.
The fluorescence lifetime imaging test method is the same as that in example 1, and the result of the gold nanorod/DNA/carbon dot nano hybrid material in fluorescence lifetime imaging is similar to that in example 1.
Example 7
The material preparation method is the same as that of example 1, and only differs from the following method: in the step 4), "the reaction time of carbon points and DNA 24 h" is changed to "12 h". The absorption peaks of the gold nanorod/DNA/carbon dot in the ultraviolet visible absorption spectrum are 516 nm and 763nm, and the emission peak of the fluorescence emission spectrum is 400-500 nm.
The diffuse reflection imaging test method is the same as that of the embodiment 1, and the performance of the gold nanorod/DNA/carbon dot nano hybrid material in diffuse reflection imaging is similar to that of the embodiment 1.
The fluorescence lifetime imaging test method is the same as that in the example 1, and the result of the gold nanorod/DNA/carbon dot nano hybrid material in the fluorescence lifetime imaging is similar to that in the example 1.
Example 8
The material preparation method is the same as that of example 1, and only differs from the following method: in step 4) "the molar ratio of the coupling agent to the carbon dots is 100: 1" is changed to "500: 1". The absorption peaks of the gold nanorod/DNA/carbon dot in the ultraviolet visible absorption spectrum are 519 and 764nm, and the emission peak of the fluorescence emission spectrum is 400-500 nm.
The diffuse reflection imaging test method is the same as that of the embodiment 1, and the performance of the gold nanorod/DNA/carbon dot nano hybrid material in diffuse reflection imaging is similar to that of the embodiment 1.
The fluorescence lifetime imaging test method is the same as that in the example 1, and the result of the gold nanorod/DNA/carbon dot nano hybrid material in the fluorescence lifetime imaging is similar to that in the example 1.
Example 9
The material preparation method is the same as that of example 1, and only differs from the following method: in the step 5), "the molar ratio of the carbon points to the gold nanorods is 20: 1" is changed into "40: 1". The absorption peaks of the gold nanorod/DNA/carbon dot in the ultraviolet visible absorption spectrum are 525 nm and 770nm, and the emission peak of the fluorescence emission spectrum is 400-500 nm.
The diffuse reflection imaging test method is the same as that of the embodiment 1, and the performance of the gold nanorod/DNA/carbon dot nano hybrid material in diffuse reflection imaging is similar to that of the embodiment 1.
The fluorescence lifetime imaging test method is the same as that in the example 1, and the result of the gold nanorod/DNA/carbon dot nano hybrid material in the fluorescence lifetime imaging is similar to that in the example 1.
Comparative example 1
Preparation of gold nanorods/DNA was the same as in example 1, steps 1) and 2).
The diffuse reflection imaging test in example 1 was repeated except that "the dispersion of gold nanorods/DNA/carbon dot nano-hybrid material" was changed to "gold nanorods/DNA dispersion". The combination of FIG. 4 shows that the slope of gold nanorod/DNA is lower than that of gold nanorod/DNA/carbon dot, and the diffuse reflection imaging effect is poor.
The fluorescence lifetime imaging test in example 1 was repeated except that "the dispersion of gold nanorods/DNA/carbon dot hybrid nanomaterial" was changed to "gold nanorod/DNA dispersion". The combination of FIG. 5 shows that the imaging effect of the gold nanorods/DNA is similar to that of the blank group, no obvious fluorescence corresponding signal exists, and the fluorescence lifetime imaging effect is poor.
Comparative example 2
Preparation of gold nanorods/DNA/carbon dots As in example 1, except that the precursor for preparing the carbon dots in step 3) was changed from "citric acid and ethylenediamine" to "ethylenediamine". As the prepared carbon dots only have amino groups and do not have carboxyl groups, the prepared carbon dots can not be covalently connected with amino-modified DNA2, and a stable gold nanorod/DNA/carbon dot nano hybrid material can not be formed.
The diffuse reflection imaging test in the example 1 is repeated, and the result shows that the slope is similar to the slope of the gold nanorod/DNA, lower than the slope of the gold nanorod/DNA/carbon dot, and the diffuse reflection imaging effect is poorer.
The fluorescence lifetime imaging test in example 1 was repeated, and the results showed that there was no significant fluorescence response signal and the fluorescence lifetime imaging effect was poor.
It should be understood that the above-mentioned embodiments of the present invention are only examples for clearly illustrating the present invention, and are not intended to limit the embodiments of the present invention, and it will be obvious to those skilled in the art that other variations or modifications may be made on the basis of the above description, and all embodiments may not be exhaustive, and all obvious variations or modifications may be included within the scope of the present invention.
SEQUENCE LISTING
<110> research institute of physical and chemical technology of Chinese academy of sciences
<120> gold nanorod/DNA/carbon dot nano hybrid material, and preparation method and application thereof
<130> JLP20I0224
<160> 4
<170> PatentIn version 3.5
<210> 1
<211> 20
<212> DNA
<213> Artificial Synthesis
<400> 1
agtcagtaca gtcattgcgt 20
<210> 2
<211> 20
<212> DNA
<213> Artificial Synthesis
<400> 2
acgcaatgac tgtactgact 20
<210> 3
<211> 40
<212> DNA
<213> Artificial Synthesis
<400> 3
gtcgcctgca tgagctgaga agtcagtaca gtcattgcgt 40
<210> 4
<211> 40
<212> DNA
<213> Artificial Synthesis
<400> 4
acgcaatgac tgtactgact tctcagctca tgcaggcgac 40
Claims (14)
1. A gold nanorod/DNA/carbon dot nano hybrid material for diffuse reflection imaging and fluorescence lifetime imaging is characterized by comprising: gold nanorods, double-stranded DNA molecules, and carbon dots;
the double-stranded DNA molecule comprises single-stranded DNA1 and complementary single-stranded DNA 2;
the 5 'end of the single-stranded DNA1 is combined with the gold nanorod through a gold-sulfur coordination bond, and the 5' end of the single-stranded DNA2 is combined with the carbon point through a covalent bond; the 5' end of the single-stranded DNA1 is modified with sulfydryl and forms a gold-sulfur coordination bond with the gold nanorod; the 5' -end of the single-stranded DNA2 is modified with amino or carboxyl;
the particle size of the carbon dots is 1-10nm, and the fluorescence lifetime is 1.0-15.0 ns; the carbon point is modified with a functional group and reacts with an amino group or a carboxyl group at the 5' end of the single-stranded DNA2 to form a covalent bond.
2. The gold nanorod/DNA/carbon dot hybrid nanomaterial according to claim 1, wherein the gold nanorod has an aspect ratio of 2-6, a diameter of 10-30nm, and a length of 20-100 nm.
3. The gold nanorod/DNA/carbon dot hybrid nanomaterial according to claim 1, wherein the modified functional group on the carbon dot is a carboxyl group or an amino group.
4. A method for preparing gold nanorod/DNA/carbon dot nano hybrid material according to any one of claims 1 to 3, which is characterized by comprising the following steps:
1) preparing gold nanorods;
2) reacting the single-stranded DNA1 with the gold nanorods to form gold-sulfur coordination bonds, and preparing a gold nanorod/DNA 1 compound;
3) preparing carbon dots containing functional groups;
4) reacting the carbon dot containing the functional group with the single-stranded DNA2 to form a covalent bond, and preparing a carbon dot/DNA 2 complex;
5) self-assembling the gold nanorod/DNA 1 compound obtained in the step 2) and the carbon dot/DNA 2 compound obtained in the step 4) in a PBS buffer solution to form the gold nanorod/DNA/carbon dot nano hybrid material.
5. The method of claim 4, wherein the single-stranded DNA1 is modified at its 5 'terminus with a thiol group and the single-stranded DNA2 is modified at its 5' terminus with an amino group.
6. The method according to claim 4, wherein the step 2) comprises:
single-stranded DNA1 and gold nanorods were added to the buffer in this order, and the reaction was carried out with shaking at room temperature.
7. The preparation method according to claim 4, wherein the molar ratio of the single-stranded DNA1 to the gold nanorods is 250:1-1000:1, and the reaction time is 0.5h-24 h.
8. The method according to claim 4, wherein step 3) comprises:
taking organic carboxylic acid or organic amine as a precursor and deionized water as a solvent, preparing a carbon dot crude product by a hydrothermal method, and dialyzing and purifying to obtain the carbon dot.
9. The method as claimed in claim 8, wherein the hydrothermal method has a reaction temperature of 120 ℃ and 200 ℃ and a reaction time of 4-12 h.
10. The method according to claim 8, wherein the organic carboxylic acid is one or a combination of two or more of citric acid, a lower fatty acid, and an amino acid; the organic amine is one or the combination of more than two of ethylenediamine, aniline, phenylenediamine, diethanolamine and hydrazine hydrate.
11. The preparation method according to claim 4, wherein the step 4) specifically comprises:
adding a coupling agent into the aqueous solution of the carbon dots containing the functional groups for activation, then adding the single-stranded DNA2, and carrying out the reaction by shaking in the dark.
12. The production method according to claim 11, wherein the coupling agent is one or a combination of two or more of 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride, dicyclohexylcarbodiimide, N-hydroxythiosuccinimide, and N-hydroxysuccinimide; the activation time is 15-30 min;
the molar ratio of the carbon point containing the functional group to the single-stranded DNA2 is 50:1-500:1, and the molar ratio of the coupling agent to the carbon point containing the functional group is 100:1-1000: 1.
13. The production method according to claim 4, wherein the molar ratio of the carbon dots to the gold nanorods in step 5) is 10:1 to 50: 1.
14. Use of the gold nanorod/DNA/carbon dot hybrid nanomaterial as defined in any one of claims 1-3 in preparation of diffuse reflection imaging and fluorescence lifetime imaging materials.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010296389.4A CN111635752B (en) | 2020-04-15 | 2020-04-15 | Gold nanorod/DNA/carbon dot nano hybrid material and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010296389.4A CN111635752B (en) | 2020-04-15 | 2020-04-15 | Gold nanorod/DNA/carbon dot nano hybrid material and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111635752A CN111635752A (en) | 2020-09-08 |
CN111635752B true CN111635752B (en) | 2022-09-23 |
Family
ID=72326565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010296389.4A Active CN111635752B (en) | 2020-04-15 | 2020-04-15 | Gold nanorod/DNA/carbon dot nano hybrid material and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111635752B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106367510A (en) * | 2016-09-20 | 2017-02-01 | 江南大学 | Preparation method and application of satellite-shaped nanometer assembling body used for duplex detection of intracellular cancer biomarker |
CN106983874A (en) * | 2017-04-11 | 2017-07-28 | 中国科学院理化技术研究所 | A kind of gold nanorods/polyethylene glycol/carbon point nano hybridization imaging contrast material and its preparation method and application |
-
2020
- 2020-04-15 CN CN202010296389.4A patent/CN111635752B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106367510A (en) * | 2016-09-20 | 2017-02-01 | 江南大学 | Preparation method and application of satellite-shaped nanometer assembling body used for duplex detection of intracellular cancer biomarker |
CN106983874A (en) * | 2017-04-11 | 2017-07-28 | 中国科学院理化技术研究所 | A kind of gold nanorods/polyethylene glycol/carbon point nano hybridization imaging contrast material and its preparation method and application |
Non-Patent Citations (3)
Title |
---|
DNA as a Powerful Tool for Morphology Control, Spatial Positioning,and Dynamic Assembly of Nanoparticles;Li Huey Tan et al.;《Accounts of Chemical Research》;20140528;第47卷;第1881-1890页"摘要、第1882页左栏最后一段以及第1883页第3.1节" * |
Hierarchical Plasmonic Nanorods and Upconversion Core–Satellite Nanoassemblies for Multimodal Imaging-Guided Combination Phototherapy;Maozhong Sun et al.;《Adv. Mater.》;20161231;第28卷;第898–904页 * |
Multimodal bioimaging based on gold nanorod and carbon dot nanohybrids as a novel tool for atherosclerosis detection;Xiaojing Liu et al.;《Nano Research》;20171231;第1-12页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111635752A (en) | 2020-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Su et al. | Carbon dots: a booming material for biomedical applications | |
Alaghmandfard et al. | Recent advances in the modification of carbon-based quantum dots for biomedical applications | |
Mahato et al. | Gold nanoparticle surface engineering strategies and their applications in biomedicine and diagnostics | |
Xing et al. | Nanodiamonds for nanomedicine | |
Jin et al. | Amorphous silica nanohybrids: Synthesis, properties and applications | |
Shi et al. | Fluorescent carbon dots for bioimaging and biosensing applications | |
EP2735543A2 (en) | Volume production method for uniformly sized silica nanoparticles | |
US20120178099A1 (en) | Highly fluorescent carbon nanoparticles and methods of preparing the same | |
CN106620725B (en) | Optical and photoacoustic integrated bimodal molecular imaging probe and preparation method and application thereof | |
CN102259834B (en) | Method for manufacturing asymmetric tetrahedron assembly structure with chiral signal | |
US20100189650A1 (en) | Near-Infrared Responsive Carbon Nanostructures | |
CN111803629A (en) | Organic-inorganic hybrid multifunctional biological material based on nano cellulose crystals and preparation method and application thereof | |
CN114346253B (en) | Preparation method of silver nanocluster-palladium composite nanosheets, product and application thereof | |
US20090075396A1 (en) | Biosensors | |
CN109097356B (en) | Preparation method of chiral pentamer assembly based on gold shell-up-conversion nanoparticles | |
Dhamodharan et al. | Carbon nanodots: Synthesis, mechanisms for bio-electrical applications | |
ul Ain et al. | Copper sulfide nanostructures: synthesis and biological applications | |
CN112156192A (en) | Composite nano probe with targeted fluorescence/magnetic resonance bimodal imaging and photothermal therapy functions and preparation and application thereof | |
CN106983874B (en) | Gold nanorod/polyethylene glycol/carbon dot nano hybrid imaging contrast material and preparation method and application thereof | |
CN112548112A (en) | Gold nanorod particles and preparation method and application thereof | |
Singh et al. | Biomedical applications of nanomaterials: an overview | |
Iannazzo et al. | Graphene-based materials for application in pharmaceutical nanotechnology | |
CN111635752B (en) | Gold nanorod/DNA/carbon dot nano hybrid material and preparation method and application thereof | |
Datta et al. | Fluorescent Nanomaterials and Its Application in Biomedical Engineering | |
CN105364066B (en) | A kind of method that golden nanometer particle surface in ionic liquid is modified |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |